Cranberry Solution
NDC Package 22840-5720-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Cranberry (vaccinium macrocarpon) solution is cranberry has been used for reducing the risk of "bladder infections" (urinary tract infections). This formulation utilizes a solution delivery system. Marketed by Greer Laboratories, Inc., this product is identified by NDC 22840-5720 and is authorized under FDA application BLA101833.

Identification & Billing

NDC Package Code
22840-5720-2
Package Description
10 mL in 1 VIAL, MULTI-DOSE
Product Code
22840-5720
11-Digit Billing Format
22840572002
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Cranberry
Non-Proprietary Name
Vaccinium Macrocarpon
Substance Name
Cranberry
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
  • Intradermal - Administration within the dermis.
  • Percutaneous - Administration through the skin.
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
Active Ingredient(s)
CRANBERRY .025 g/mL
Pharmacologic Class
Usage Information
Cranberry has been used for reducing the risk of "bladder infections" (urinary tract infections). It has also been used for decreasing the smell of urine in people who are unable to control urination (incontinent). This product should not be used alone to treat bladder infections. It may not work, and the delay could allow the infection to worsen. Some herbal/diet supplement products have been found to contain possibly harmful impurities/additives. Check with your pharmacist for more details about the brand you use. The FDA has not reviewed this product for safety or effectiveness. Consult your doctor or pharmacist for more details.

Regulatory & Marketing

Labeler Name
Greer Laboratories, Inc.
Product Type
Non-standardized Allergenic
FDA Application #
BLA101833
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
09-15-1981
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (22840-5720). Click a package code to view its specific billing and regulatory data.

22840-5720-5
5 mL in 1 BOTTLE, DROPPER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 22840-5720-2 identifies a specific commercial package of 10 ml in 1 vial, multi-dose of Cranberry, a non-standardized allergenic label labeled by Greer Laboratories, Inc.. This solution is formulated for intradermal; percutaneous; subcutaneous use and contains cranberry as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Greer Laboratories, Inc. on September 15, 1981. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Cranberry has been used for reducing the risk of "bladder infections" (urinary tract infections). It has also been used for decreasing the smell of urine in people who are unable to control urination (incontinent). This product should not be used alone to treat bladder infections. It may not work, and the delay could allow the infection to worsen. Some herbal/diet supplement products have been found to contain possibly harmful impurities/additives. Check with your pharmacist for more details about the brand you use. The FDA has not reviewed this product for safety or effectiveness. Consult your doctor or pharmacist for more details.

How is this Greer Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 22840572002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
22840-5720-2
11-Digit CMS (5-4-2)
22840-5720-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.